Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,185.23, with a 24-hour trading volume of $1.3B. The asset's market cap is $1.05T, after moving 0.28% in the last day.
Tokenized Eli Lilly And Co is trading at $1,186.6, with a tokenized market cap of $7.35M and a 24-hour trading volume of $4.59M. The tokenized asset has moved 0.02% in the past 24 hours.